Hematuria other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
=== '''Intravenous Urography (IVU)''' === | === '''Intravenous Urography (IVU)''' === | ||
'''Advantages''' | '''Advantages''' | ||
* IVU is good at detecting abnormalities of the [[urothelium]] (UCC of the ureter and renal pelvis) and stones. | * IVU is good at detecting abnormalities of the [[urothelium]] (UCC of the ureter and renal pelvis) and stones.<ref name="pmid24364522">Sharp VJ, Barnes KT, Erickson BA (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=24364522 Assessment of asymptomatic microscopic hematuria in adults.] ''Am Fam Physician'' 88 (11):747-54. PMID: [https://pubmed.gov/24364522 24364522]</ref> | ||
'''Disadvantages''' | '''Disadvantages''' | ||
* Poor at detecting small renal parenchymal lesions that do not distort the renal outline. | * Poor at detecting small renal parenchymal lesions that do not distort the renal outline. | ||
Line 17: | Line 17: | ||
'''Advantages''' | '''Advantages''' | ||
* Used to investigate [[intravenous urography]] filling defects and to treat stones. | * Used to investigate [[intravenous urography]] filling defects and to treat stones. | ||
* In patient with continued undiagnosed hematuria, this can be used to collect urine or brushings from each ureter, allowing cytology to determine the site of bleeding and the presence of very small tumors of carcinoma in-situ. | * In patient with continued undiagnosed hematuria, this can be used to collect urine or brushings from each ureter, allowing cytology to determine the site of bleeding and the presence of very small tumors of carcinoma in-situ.<ref name="pmid27261791">Avellino GJ, Bose S, Wang DS (2016) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=27261791 Diagnosis and Management of Hematuria.] ''Surg Clin North Am'' 96 (3):503-15. [http://dx.doi.org/10.1016/j.suc.2016.02.007 DOI:10.1016/j.suc.2016.02.007] PMID: [https://pubmed.gov/27261791 27261791]</ref> | ||
'''Disadvantages''' | '''Disadvantages''' | ||
* Requires general anaesthesia for the procedure. | * Requires general anaesthesia for the procedure. |
Revision as of 05:44, 30 January 2017
Hematuria Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hematuria other imaging findings On the Web |
American Roentgen Ray Society Images of Hematuria other imaging findings |
Risk calculators and risk factors for Hematuria other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Other imaging studies for hematuria include intravenous urography, endoscopy, magnetic resonance imaging.[1]
Other Imaging Findings
Intravenous Urography (IVU)
Advantages
- IVU is good at detecting abnormalities of the urothelium (UCC of the ureter and renal pelvis) and stones.[2]
Disadvantages
- Poor at detecting small renal parenchymal lesions that do not distort the renal outline.
- It cannot distinguish cystic from solid masses.
Endoscopy/ Fluoroscopy
Advantages
- Used to investigate intravenous urography filling defects and to treat stones.
- In patient with continued undiagnosed hematuria, this can be used to collect urine or brushings from each ureter, allowing cytology to determine the site of bleeding and the presence of very small tumors of carcinoma in-situ.[3]
Disadvantages
- Requires general anaesthesia for the procedure.
Magnetic Resonance Imaging (MRI)
Advantages
- MRI can been used for equivocal cases and planning treatment.
- Has a high specificity and sensitivity for investigating the causes of hematuria.
- Useful in the setting of a contraindication (e.g. Pregnancy, Iodinated contrast allergy, Renal insufficiency) to CT urogram.
Disadvantages
- MRI is expensive.
- Contraindicated in patients with specific conditions.( e.g. Pacemaker, Significant renal function compromise (i.e., estimated GFR <30) when the administration of gadolinium risks nephrogenic systemic fibrosis).
References
- ↑ Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ et al. (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188 (6 Suppl):2473-81. DOI:10.1016/j.juro.2012.09.078 PMID: 23098784
- ↑ Sharp VJ, Barnes KT, Erickson BA (2013) Assessment of asymptomatic microscopic hematuria in adults. Am Fam Physician 88 (11):747-54. PMID: 24364522
- ↑ Avellino GJ, Bose S, Wang DS (2016) Diagnosis and Management of Hematuria. Surg Clin North Am 96 (3):503-15. DOI:10.1016/j.suc.2016.02.007 PMID: 27261791